Literature DB >> 21475791

Plasma concentrations of zinc, copper, interleukin-6 and interferon-γ, and plasma dipeptidyl peptidase IV activity in chronic hepatitis C.

Kurt Grüngreiff1, Thomas Hebell, Kai Gutensohn, Annegret Reinhold, Dirk Reinhold.   

Abstract

Copper and zinc are essential trace elements which play an important role in various biological processes. Along with various cytokines, glucocorticoids, glucagon and insulin, the acute-phase protein metallothionein is involved in the regulation of immune cell functions. Metallothionein is the central protein regulating zinc concentration. Zinc deficiency is often found in patients with chronic liver disease, chronic kidney disease and diabetes mellitus, and in those with acute infectious diseases. In contrast, copper deficiency is rarely reported. In order to determine whether there is a correlation between zinc and/or copper and selected immunological parameters in patients with chronic liver disease, we investigated plasma levels of zinc and copper, concentrations of interleukin-6 (IL-6) and interferon-γ (IFN-γ), and the enzymatic activity of dipeptidyl peptidase IV (DP IV, CD26) in patients with chronic hepatitis C and in healthy control subjects. Whereas zinc plasma levels did not differ between patients and control subjects, copper concentrations revealed gender-specific differences. The mean copper concentration was higher in female patients with chronic hepatitis C and in female controls compared with the respective male groups. The immunological parameters of IFN-γ concentration and DP IV activity showed similar levels in the patient and control groups. Of note, the mean IL-6 plasma concentrations were significantly elevated in patients with chronic hepatitis C compared with healthy control subjects. In summary, there was no correlation between either zinc or copper concentrations and the immunological parameters measured (IL-6 and IFN-γ levels and DP IV activity) in patients with chronic hepatitis C and in healthy control subjects.

Entities:  

Year:  2009        PMID: 21475791     DOI: 10.3892/mmr_00000062

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  Abnormalities in Cu and Zn levels in acute hepatitis of different etiologies.

Authors:  K Papanikolopoulos; A Alexopoulou; A Dona; E Hadziyanni; L Vasilieva; S Dourakis
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

Review 2.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

3.  Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.

Authors:  Marilyn Huckans; Bret E Fuller; Hannah Olavarria; Anna W Sasaki; Michael Chang; Kenneth D Flora; Michael Kolessar; Daniel Kriz; Jeanne R Anderson; Arthur A Vandenbark; Jennifer M Loftis
Journal:  Brain Behav       Date:  2013-12-29       Impact factor: 2.708

4.  Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.

Authors:  Kessarin Thanapirom; Sirinporn Suksawatamnuay; Wattana Sukeepaisarnjaroen; Pisit Tangkijvanich; Sombat Treeprasertsuk; Panarat Thaimai; Rujipat Wasitthankasem; Yong Poovorawan; Piyawat Komolmit
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

5.  Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference?

Authors:  Mohammad Abbasinazari; Bita Behnava; Yunes Panahi; Azita Hajhossein Talasaz; Shima Salimi; Maryam Keshvari; Leila Mehrnoush; Pegah Karim Elizee; Mohammad Gholami Fesharaki; Mansour Asgharinia; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-08-12       Impact factor: 0.660

6.  Persistent low level of osterix accelerates interleukin-6 production and impairs regeneration after tissue injury.

Authors:  Wook-Young Baek; Seung-Yoon Park; Yeo Hyang Kim; Min-A Lee; Tae-Hwan Kwon; Kwon-Moo Park; Benoit de Crombrugghe; Jung-Eun Kim
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

7.  Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial.

Authors:  Shahinul Alam; Jhumur Ghosh; Golam Mustafa; Mohammad Kamal; Nooruddin Ahmad
Journal:  Hepat Med       Date:  2018-04-27

Review 8.  Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.

Authors:  Ahmed Babiker; Mohamed Hassan; Safwan Muhammed; Gregory Taylor; Bhawna Poonia; Anoop Shah; Shashwatee Bagchi
Journal:  Clin Cardiol       Date:  2019-11-30       Impact factor: 2.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.